How cells package and move proteins that affect brain health in Alzheimer's

Molecular mechanisms of coat assembly and regulation in membrane trafficking pathways

NIH-funded research Vanderbilt University · NIH-11322716

Finding how cells package and move proteins that can affect brain cells in Alzheimer's disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVanderbilt University NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project IDNIH-11322716 on NIH RePORTER

What this research studies

This research looks at the tiny protein 'coats' cells use to package and send protein-filled bubbles between cell compartments, processes important for brain cell health. Scientists use purified proteins, biochemical experiments, and structural methods such as X-ray crystallography to see how coat complexes (including COPI and retromer-related complexes) form and select cargo. They also examine accessory and regulatory proteins and the membrane-fusion machinery to learn how these systems are controlled. The work is done in the lab to reveal basic mechanisms that may connect to changes seen in Alzheimer's.

Who could benefit from this research

Good fit: This is lab-based basic research at Vanderbilt that does not enroll patients or require volunteers.

Not a fit: People seeking immediate new treatments or clinical care are unlikely to benefit directly, because the project focuses on molecular mechanisms in the lab.

Why it matters

Potential benefit: If successful, the work could point to new molecular targets for drugs or other therapies that protect brain cells in Alzheimer's disease.

How similar studies have performed: Earlier work linking trafficking proteins like retromer to Alzheimer's has shown promise, but many coat complexes remain less studied so this work extends prior findings into new mechanisms.

Where this research is happening

Nashville, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.